Frazier Life Sciences Acquisition Corp. II (NASDAQ:FLSC) CEO Albert Cha Buys 300,000 Shares of Stock

Frazier Life Sciences Acquisition Corp. II (NASDAQ:FLSC) CEO Albert Cha acquired 300,000 shares of the business’s stock in a transaction dated Thursday, October 15th. The stock was acquired at an average cost of $10.00 per share, with a total value of $3,000,000.00. Following the purchase, the chief executive officer directly owned 300,000 shares in the company, valued at $3,000,000. This represents a ∞ increase in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.

Frazier Life Sciences Acquisition Corp. II Trading Up 1.9%

FLSC stock opened at $10.49 on Friday. Frazier Life Sciences Acquisition Corp. II has a 52 week low of $10.18 and a 52 week high of $10.50.

Frazier Life Sciences Acquisition Corp. II Company Profile

Frazier Life Sciences Acquisition Corp. II is a special purpose acquisition company, or SPAC, focused on identifying and combining with a business in the life sciences sector. The company does not operate a conventional commercial business and was formed to pursue a merger, acquisition, or similar business combination.

Its target opportunities may include companies involved in biotechnology, pharmaceuticals, medical devices, diagnostics, or other healthcare-related technologies. The company’s objective is to provide a publicly traded platform for a private life sciences business through a business combination.

Frazier Life Sciences Acquisition Corp.